![Jude Onyia](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jude Onyia
Technik-/Wissenschafts-/F&E-Leiter bei
NEUROCRINE BIOSCIENCES, INC.
Vermögen: 4 Mio $ am 30.06.2026
Profil
Currently, Jude Onyia is Director at Voyager Therapeutics, Inc. since 2023 and Chief Scientific Officer at Neurocrine Biosciences, Inc. since 2021.
Formerly, Dr. Onyia was Vice President-Biotechnology Discovery Research at Eli Lilly & Co. from 2014 to 2021 and Chief Scientific Officer at Capsida Biotherapeutics, Inc. in 2021.
Education includes a doctorate from State University of New York at Downstate Medical Center, an undergraduate degree from Suny College of Environmental Science & Forestry, and a doctorate from SUNY Upstate Medical University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 23’405 ( 0.02% ) | 4 Mio $ | 30.06.2026 | |
| 09.06.2026 | 2’910 ( 0% ) | 10 185 $ | 30.06.2026 |
Aktive Positionen von Jude Onyia
| Unternehmen | Position | Beginn |
|---|---|---|
| NEUROCRINE BIOSCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.11.2021 |
| VOYAGER THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 21.02.2023 |
Ehemalige bekannte Positionen von Jude Onyia
| Unternehmen | Position | Ende |
|---|---|---|
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01.06.2021 |
Ausbildung von Jude Onyia
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
78
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
SUNY College of Environmental Science
 SUNY College of Environmental Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SUNY Upstate Medical University
 SUNY Upstate Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York at Downstate Medical Center
 State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
 Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
Wählen Sie MarketScreener 
